Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 mutation status in Japanese HER2-negative breast cancer patients.

Japanese journal of clinical oncology - 1 Jul 2014

Endo Yumi, Dong Yu, Yoshimoto Nobuyasu, Asano Tomoko, Hato Yukari, Yamashita Hiroko, Sato Shinya, Takahashi Satoru, Fujii Yoshitaka, Toyama Tatsuya

Abstract excerpt

OBJECTIVE: Human epidermal growth factor receptor 2 (HER2) gene amplification is a major therapeutic target in breast cancer, and has been introduced as a predictive biomarker to identify patients who may benefit from therapy with anti-human epidermal growth factor receptor 2 agents. Human epider...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspartic Acid
Share to Carcinoma, Ductal, Breast
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoleucine

Share to Methionine

Share to Neoplasm Grading

Share to Receptor, ErbB-2

Share to Tyrosine

Source

Identifiers

PMID: 24803549
DOI: 10.1093/jjco/hyu053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-24803549-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 mutation status in Japanese HER2-negative breast cancer patients.PMID 24803549Read ↗

HER2 mutation status in Japanese HER2-positive breast cancer patients.Semantic proximity Read ↗

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast CancerSemantic proximity Read ↗

HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.Semantic proximity Read ↗

Activating HER2 mutations in HER2 gene amplification negative breast cancer.Semantic proximity Read ↗

Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis.Semantic proximity Read ↗

Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2.Semantic proximity Read ↗

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers.Semantic proximity Read ↗

Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature.Semantic proximity Read ↗

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.Semantic proximity Read ↗

Analysis of different HER-2 mutations in breast cancer progression and drug resistance.Semantic proximity Read ↗

Somatic mutations of the HER2 in metastatic breast cancer.Semantic proximity Read ↗

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.